Showing results (301-310 of 372) with videos related to
Sort By:
Pageof 38
Cancer Cell|January 27, 2015
Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progressionIsaac S Harris, Aislinn E Treloar, Satoshi Inoue, et al.Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.Acta Neuropathologica|September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaDaniel Picard, Jörg Felsberg, Maike Langini, et al.Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.Cancer Cell|March 26, 2019
Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial DiagnosisVerena Körber, Jing Yang, Pankaj Barah, et al.Cell Metabolism|March 28, 2020
Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell FunctionHenry Kurniawan, Davide G Franchina, Luana Guerra, et al.The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.Pageof 38